4 markers to predict C. diff mortality risk

A new research paper in BMC Infectious Diseases identifies a four-point test using easily measurable clinical variables to accurately identify patients at risk of dying from Clostridium difficile (C. diff) infection.

The researchers determined the four points of the test by analyzing the clinical notes of 213 patients who had been transferred to the Royal Devon & Exeter NHS Foundation Trust (RD&E) specialized C. diff ward between 2007 and 2009. They then examined additional information gathered while the patients were in the hospital and in a follow-up at least 30-days after discharge.

The test involves four easily measurable clinical variables:

1. Serum albumin levels (protein in blood plasma)

2. Respiratory rate

3. C-reactive protein (a protein found in blood, the levels of which rise in inflammation)

4.  White cell count

The researchers acknowledge the clinical team can't definitely blame an increase or decrease in these markers on C. diff alone but note it can generally link an acute rise or decline in these variables around the time of infection diagnosis to C. diff.

And because the test uses only four variables, its simplicity would enable non-specialists to perform assessments within or around 48 hours of C. diff diagnosis--leading to the ability to assess more patients and establish interventions, the study noted.

Moreover, with accurate prediction, clinicians can appropriately manage at-risk patients and adjust the treatment plan after identifying a high-mortality risk, according to the research announcement.

"This really simple and quick tool, which any junior doctor could use in the middle of the night quickly and easily, flags up those who need a speedy and intensive treatment regime or more senior help," Ray Sheridan, consultant physician at the RD&E, said in the announcement. "The quicker we get on with the right treatment for the right patient the better their chances of recovery are."

Meanwhile, research in the May issue of the American Journal of Infection Control showed testing patients with three independent risk factors--recent hospitalization, chronic dialysis and corticosteroid use--when they're admitted could help hospitals identify asymptomatic C. diff. carriers.

For more:
- here's the research announcement
- check out the research article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.